Skip Navigation

Annals of Oncology 2007 18(8):1408-1413; doi:10.1093/annonc/mdm127
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Janssen-Heijnen, M.
Right arrow Articles by Coebergh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janssen-Heijnen, M.
Right arrow Articles by Coebergh, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

epidemiology

Prognosis for long-term survivors of cancer

MLG Janssen-Heijnen1,*, S Houterman1,2, VEPP Lemmens1,3, H Brenner4, EW Steyerberg3 and JWW Coebergh1,3

1 Eindhoven Cancer Registry, Comprehensive Cancer Centre South, AE Eindhoven
2 MMC Academy, Máxima Medical Centre, Veldhoven
3 Department of Public Health, Erasmus MC—University Medical Centre Rotterdam, Rotterdam, The Netherlands
4 Division of Clinical Epidemiology and Aging Research, German Cancer Research Centre, Heidelberg, Germany

* Correspondence to: M. L. G. Janssen-Heijnen, Eindhoven Cancer Registry, PO Box 231, 5600 AE Eindhoven, The Netherlands. Tel: +31 40 2971616; Fax: +31 40 2971610; E-mail: research{at}ikz.nl

Background: Many cancer patients who have already survived some time want to know about their prognosis, given the pre-condition that they are still alive. We described and interpreted population-based conditional 5-year relative survival rates.

Patients and methods: The long-standing Eindhoven Cancer Registry collects data on all patients diagnosed with cancer in the southern part of the Netherlands. Patients aged 25–74 years, diagnosed between 1960 and 2004, were included. Conditional 5-year relative survival was computed for every additional year survived (follow-up period 1980–2004).

Results: For patients with colorectal cancer, cutaneous melanoma or stage I breast cancer, conditional 5-year relative survival was >95% after having survived 3–15 years. However, for stomach, lung, stage II or III breast, prostate cancer or Hodgkin lymphoma, conditional 5-year relative survival did not exceed 75–94%. Initial differences in survival at diagnosis between age, gender and stage groups largely disappeared after having survived for 5–10 years.

Conclusion: Prognosis for patients with cancer generally improved with each year survived. Patients with colorectal cancer, cutaneous melanoma or stage I breast cancer hardly exhibit any excess mortality after 3–15 years, whereas for patients with other tumours survival remained poorer than for the general population. Insight into conditional survival is especially useful for (ex)patients, who may use this information to plan their remaining life.

Key words: cancer, conditional survival, long-term prognosis, period survival, population-based

Received for publication November 1, 2006. Revision received March 14, 2007. Accepted for publication March 14, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.